Periodontitis appears to be an inflammatory response to a specific, albeit chronic, bacteriological infection associated primarily with the overgrowth of certain anaerobic organisms. These findings indicate that treatments aimed at controlling periodontitis should contain an antimicrobial component directed to the reduction, if not the elimination, of the periodontopathic organisms from the plaque. We have conducted 4 double-blind (DB) studies that have shown that the unsupervised usage of Metronidazole (MET) for 1 to 2 weeks plus scaling and root planing (S/RP), will reduce the need for periodontal surgery, increase attachment level, reduce probing depths, and reduce the levels and proportions of certain anaerobic organisms in the plaque, relative to a regimen consisting of the unsupervised usage of placebo plus S/RP. We have shown in the ongoing DB study, that Doxycycline (DOX) (a tetracycline analogue) will give results comparable to those obtained with MET. Antimicrobials used in this fashion will reduce the periodontal surgical needs by about 62% (DOX) to 76% (MET), compared to baseline values. Additional reduction of 10 to 15% can be obtained by placing ethylcellulose films containing MET or chlorhexidine (CHX) into pockets of teeth still requiring surgery after the systemic medication, thereby giving an overall reduction in surgical needs of about 90%. These results support the hypothesis that most advanced forms of periodontitis can be successfully treated by the combination of root surface debridement and short-term usage of systemic antimicrobial agents. We have in these DB studies, obtained answers to questions relating to who to treat? when to treat? how long to treat? how do you know that the treatment works? There remain unanswered, or still unaddressed, issues which we expect to answer with this competing renewal. We do not have enough data to determine which of the locally delivered agents is best. We do not know what the rate of reoccurrence of periodontitis will be in these patients 2 to 8 years following successful treatment. In the studies to be described we will determine the rate of recidivism of periodontitis following treatment with systemic and locally delivered antimicrobial agents. In particular, we will look for clinical and bacteriological predictors of relapse during the 2 to 8 years following the initial treatment. We will also determine, using a DB design, whether the delivery of antimicrobial agents via a slow release delivery system can achieve a reduction in surgical needs comparable to that which we have observed with systemic MET or DOX.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE006030-10
Application #
2129295
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1982-07-01
Project End
1998-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
10
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Biology
Type
Schools of Dentistry
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Loesche, Walter J; Giordano, James R; Soehren, Stephen et al. (2005) The nonsurgical treatment of patients with periodontal disease: results after 6.4 years. Gen Dent 53:298-306; quiz 307
Loesche, Walter J; Giordano, James R; Soehren, Stephen et al. (2002) The nonsurgical treatment of patients with periodontal disease: results after five years. J Am Dent Assoc 133:311-20
Loesche, W J; Grossman, N S (2001) Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 14:727-52, table of contents
Loesche, W J (1999) The antimicrobial treatment of periodontal disease: changing the treatment paradigm. Crit Rev Oral Biol Med 10:245-75
Loesche, W J; Giordano, J R (1997) Treatment paradigms in periodontal disease. Compend Contin Educ Dent 18:221-6, 228-30, 232 passim; quiz
Loesche, W J; Taylor, G; Giordano, J et al. (1997) A logistic regression model for the decision to perform access surgery. J Clin Periodontol 24:171-9
Loesche, W J; Giordano, J; Soehren, S et al. (1996) Nonsurgical treatment of patients with periodontal disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:533-43
De Boever, E H; De Uzeda, M; Loesche, W J (1994) Relationship between volatile sulfur compounds, BANA-hydrolyzing bacteria and gingival health in patients with and without complaints of oral malodor. J Clin Dent 4:114-9
Loesche, W J; Giordano, J R (1994) Metronidazole in periodontitis V: debridement should precede medication. Compendium 15:1198, 1201, 1203 passim;quiz 12
Loesche, W J; Grossman, N; Giordano, J (1993) Metronidazole in periodontitis (IV). The effect of patient compliance on treatment parameters. J Clin Periodontol 20:96-104

Showing the most recent 10 out of 23 publications